Prostate Cancer and Prostatic Diseases

(ISSN: 1365-7852, 1476-5608)

This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.

Articles Available on Medscape

 
 

Table of Contents

From Prostate Cancer and Prostatic Diseases

2018 -

  • Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning. 
  • Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer. 
  • Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data. 
  • Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage. 
  • Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer. 
  • Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test. 
  • Reply to Letter to the Editor re: 'Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting'. 
  • Addition of abiraterone, docetaxel, bisphosphonate, celecoxib or combinations to androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC): a network meta-analysis. 
 
 

Journal Information

Mission Statement: Prostate Cancer and Prostatic Diseases, covering all aspects of prostate disease (including BPH and cancer).